Videos
Advertisement
Advertisement
Trending on Urology Times
1
Mina Fam, MD, highlights significance of tebipenem pivoxil approval for cUTI
2
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
3
Retrospective study suggests differences in OAB therapy persistence among older adults
4
Sandip Prasad, MD, highlights 3-year data on mitomycin for intravesical solution for LG-IR-NMIBC
5